Literature DB >> 15210737

The limits of limited stage lymphoma.

Thomas P Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15210737     DOI： 10.1200/JCO.2004.05.926

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

1.  Prognostic implications of tumor extent in early-stage diffuse large B-cell lymphoma.

Authors:  Changhoon Yoo; Dok Hyun Yoon; Jeong Eun Kim; Jungmin Jo; Seong Joon Park; Shin-Kyo Yoon; Yongchel Ahn; Shin Kim; Jooryung Huh; Dae Ho Lee; Cheolwon Suh
Journal:  Int J Hematol       Date:  2013-01-29       Impact factor: 2.490

2.  Periampullary lymphoma masquerading as adenocarcinoma.

Authors:  K N Lokesh; K C Lakshmaiah; C S Premalata; D Lokanatha
Journal:  Indian J Surg Oncol       Date:  2013-03-28

3.  [Consolidation radiotherapy in primary gastric diffuse large B‑cell lymphoma with post-chemotherapy complete remission].

Authors:  Christina Jentsch
Journal:  Strahlenther Onkol       Date:  2016-07       Impact factor: 3.621

4.  Pancreatic tumor: when is it not pancreatic adenocarcinoma?

Authors:  Eugene Zolotarevsky; Robert C Kurtz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-12

5.  Non-Hodgkin's lymphoma in the elderly.

Authors:  Paolo F Caimi; Paul M Barr; Nathan A Berger; Hillard M Lazarus
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

6.  Limited-stage DLBCL: it's patient selection.

Authors:  Daniel O Persky
Journal:  Blood       Date:  2018-01-11       Impact factor: 22.113

7.  Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

Authors:  Sally F Barrington; N George Mikhaeel; Lale Kostakoglu; Michel Meignan; Martin Hutchings; Stefan P Müeller; Lawrence H Schwartz; Emanuele Zucca; Richard I Fisher; Judith Trotman; Otto S Hoekstra; Rodney J Hicks; Michael J O'Doherty; Roland Hustinx; Alberto Biggi; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

8.  Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001.

Authors:  Daniel O Persky; Hongli Li; Deborah M Stephens; Steven I Park; Nancy L Bartlett; Lode J Swinnen; Paul M Barr; Jerome D Winegarden; Louis S Constine; Thomas J Fitzgerald; John P Leonard; Brad S Kahl; Michael L LeBlanc; Joo Y Song; Richard I Fisher; Lisa M Rimsza; Sonali M Smith; Thomas P Miller; Jonathan W Friedberg
Journal:  J Clin Oncol       Date:  2020-07-13       Impact factor: 44.544

9.  Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis.

Authors:  Martin D Berger; Sven Trelle; Annina E Büchi; Sabrina Jegerlehner; Codruta Ionescu; Thierry Lamy de la Chapelle; Urban Novak
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

10.  Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis.

Authors:  Junshik Hong; Ae Jin Kim; Jin Sun Park; Seok Ho Lee; Kyu Chan Lee; Jinny Park; Sun Jin Sym; Eun Kyung Cho; Dong Bok Shin; Jae Hoon Lee
Journal:  Korean J Hematol       Date:  2010-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.